Subscribe to RSS

DOI: 10.1055/s-0044-1787105
Preosteoblast Adhesion and Viability Study of Freeze-Dried Bovine Bone Block Scaffold Coated with Human Umbilical Cord Mesenchymal Stem Cell Secretome
Authors

Abstract
Objectives Combining a three-dimensional scaffold with growth factors before implantation is one method used to increase scaffold bioactivity in bone tissue engineering. The mesenchymal stem cell (MSC)–conditioned medium (CM), called secretome, contains many proteins and growth factors required for tissue repair and growth. This study evaluated the bioactivity of a bovine bone scaffold combined with the secretome of human umbilical cord MSCs (hUC-MSCs) by analyzing MC3T3-E1 cell adhesion and viability on the scaffold.
Materials and Methods This in vitro laboratory study evaluated the effect of hUC-MSC secretome applied to bovine bone scaffolds processed using various techniques on MC3T3-E1 cell adhesion and viability. The three experimental groups included deproteinized bovine bone mineral–secretome (DBBM-CM), freeze-dried bovine bone–secretome (FDBB-CM), and decellularized FDBB-CM, whereas the control group was treated with DBBM alone. The cell adhesion test was performed using the centrifugation method after 6 and 24 hours, whereas the cell viability test was conducted using the trypan blue exclusion method after 24, 48, and 72 hours. Cell attachment was visualized after 4′,6-diamidino-2-phenylindole staining and viewed under inverted fluorescence microscopy.
Stastical Analysis Statistical analyses were performed using one-way analysis of variance, followed by a post hoc test in cases of significant differences.
Results Statistical analyses showed significantly greater adhesion of the preosteoblasts to the FDBB-CM scaffold at 6 hours (p = 0.002). The results of the adhesion test at 24 hours and the viability tests at all observation times showed no significant differences (p > 0.05). This study found that the average MC3T3-E1 cell adhesions and viabilities were highest for the FDBB-CM and DBBM-CM scaffolds. DBBM scaffolds with the secretome had better cell adhesion and viability than those without the secretome.
Conclusion The addition of MSC secretome increased bovine bone scaffold bioactivity especially in DBBM and FDBB scaffolds.
Publication History
Article published online:
16 July 2024
© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Kheirallah M, Almeshaly H. Bone graft substitutes for bone defect regeneration. A collective review. Int J Dent Oral Sci 2016; 3 (05) 247-257
- 2 Kamadjaja DB, Rantam FA, Ferdiansyah Mahyudin NI, Pramono DC. Healing mechanism and osteogenic capacity of bovine bone mineral—human amniotic mesenchymal stem cell and autogenous bone graft in critical size mandibular defect. J Biomed Sci Eng 2015; 8 (10) 733-746
- 3 Mansour A, Al-Hamed FS, Torres J, Marino FT. Alveolar bone grafting: rationale and clinical applications. In: Dental Implant and Bone Grafts Material and Biological Issues. United Kingdom: Elsevier; 2020: 43-70
- 4 Miron RJ, Zhang Y. The regenerative properties of bone grafts: a comparison between autografts, allografts, xenografts, and alloplasts. In: Next Generation Biomaterials for Bone & Periodontal Regeneration. China: Quintessence Publishing; 2019: 1-13
- 5 Marantson N, Kamadjaja DB, Rizqiawan A. et al. Cell attachment and biocompatibility analysis of freeze-dried bovine bone scaffold and decellularized freeze-dried bovine bone scaffold on human-umbilical cord mesenchymal stem culture. J Int Dent Med Res 2023; 16 (01) 97-104
- 6 Bracey DN, Seyler TM, Jinnah AH. et al. A decellularized porcine xenograft-derived bone scaffold for clinical use as a bone graft substitute: a critical evaluation of processing and structure. J Funct Biomater 2018; 9 (03) 45
- 7 Chen K, Lin X, Zhang Q. et al. Decellularized periosteum as a potential biologic scaffold for bone tissue engineering. Acta Biomater 2015; 19: 46-55
- 8 Nugraha AP, Kamadjaja DB, Sumarta NPM. et al. Osteoinductive and osteogenic capacity of freeze-dried bovine bone compared to deproteinized bovine bone mineral scaffold in human umbilical cord mesenchymal stem cell culture: an in vitro study. Eur J Dent 2023; 17 (04) 1106-1113
- 9 Zhang X, Xu H, Miron RJ, Zhang Y. Next-generation use of gene therapy for growth factor delivery. In: Next Generation Biomaterials for Bone & Periodontal Regeneration. China: Quintessence Publishing; 2019: 315-330
- 10 Kamadjaja DB, Sumarta NPM, Rizqiawan A. Stability of tissue augmented with deproteinized bovine bone mineral particles associated with implant placement in anterior maxilla. Case Rep Dent 2019; 2019: 5431752
- 11 Marolt Presen D, Traweger A, Gimona M, Redl H. Mesenchymal stromal cell-based bone regeneration therapies: from cell transplantation and tissue engineering to therapeutic secretomes and extracellular vesicles. Front Bioeng Biotechnol 2019; 7: 352
- 12 Otto L, Wolint P, Bopp A. et al. 3D-microtissue derived secretome as a cell-free approach for enhanced mineralization of scaffolds in the chorioallantoic membrane model. Sci Rep 2021; 11 (01) 5418
- 13 Wang KX, Xu LL, Rui YF. et al. The effects of secretion factors from umbilical cord derived mesenchymal stem cells on osteogenic differentiation of mesenchymal stem cells. PLoS One 2015; 10 (03) e0120593
- 14 Kafi MA, Aktar MK, Phanny Y, Todo M. Adhesion, proliferation and differentiation of human mesenchymal stem cell on chitosan/collagen composite scaffold. J Mater Sci Mater Med 2019; 30 (12) 131
- 15 O'Brien FJ, Harley BA, Yannas IV, Gibson LJ. The effect of pore size on cell adhesion in collagen-GAG scaffolds. Biomaterials 2005; 26 (04) 433-441
- 16 Malagón-Escandón A, Hautefeuille M, Jimenez-Díaz E. et al. Three-dimensional porous scaffolds derived from bovine cancellous bone matrix promote osteoinduction, osteoconduction, and osteogenesis. Polymers (Basel) 2021; 13 (24) 4390
- 17 Kamadjaja DB, Triakoso N. Purwati. Bovine bone xenograft scaffold seeded with human umbilical cord mesenchymal stem cell to reconstruct segmental defect in a dog's mandible: a preliminary study. Biochem Cell Arch 2019; 19 (02) 4871-4876
- 18 Chakar C, Naaman N, Soffer E. et al. Bone formation with deproteinized bovine bone mineral or biphasic calcium phosphate in the presence of autologous platelet lysate: comparative investigation in rabbit. Int J Biomater 2014; 2014: 367265
- 19 Kamadjaja DB, Abidin ZZ, Diana R. et al. In vivo analyses of osteogenic activity and bone regeneration capacity of demineralized freeze-dried bovine bone xenograft: a potential candidate for alveolar bone fillers. Int J Dent 2021; 2021: 1724374
- 20 Ferdiansyah F, Utomo DN, Suroto H. Immunogenicity of bone graft using xenograft freeze-dried cortical bovine, allograft freeze-dried cortical New Zealand white rabbit, xenograft hydroxyapatite bovine, and xenograft demineralized bone matrix bovine in bone defect of femoral diaphysis white rabbit experimental study in vivo. KnE Life Sciences 2017; 344-355
- 21 Bow A, Anderson DE, Dhar M. Commercially available bone graft substitutes: the impact of origin and processing on graft functionality. Drug Metab Rev 2019; 51 (04) 533-544
- 22 Cai S, Wu C, Yang W, Liang W, Yu H, Liu L. Recent advance in surface modification for regulating cell adhesion and behaviors. Nanotechnol Rev 2020; 9 (01) 971-989
- 23 Ferreira JR, Teixeira GQ, Santos SG, Barbosa MA, Almeida-Porada G, Gonçalves RM. Mesenchymal stromal cell secretome: influencing therapeutic potential by cellular pre-conditioning. Front Immunol 2018; 9: 2837
- 24 Hirashima M, Kashio Y, Nishi N. et al. Galectin-9 in physiological and pathological conditions. Glycoconj J 2002; 19 (7-9): 593-600
- 25 Habas K, Shang L. Alterations in intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1) in human endothelial cells. Tissue Cell 2018; 54: 139-143
- 26 Phelps J, Sanati-Nezhad A, Ungrin M, Duncan NA, Sen A. Bioprocessing of mesenchymal stem cells and their derivatives: toward cell-free therapeutics. Stem Cells Int 2018; 2018: 9415367
- 27 Jo YJ, Kim KH, Koo KT. et al. Initial adhesion of bone marrow stromal cells to various bone graft substitutes. J Periodontal Implant Sci 2011; 41 (02) 67-72
- 28 van den Dolder J, Bancroft GN, Sikavitsas VI, Spauwen PH, Mikos AG, Jansen JA. Effect of fibronectin- and collagen I-coated titanium fiber mesh on proliferation and differentiation of osteogenic cells. Tissue Eng 2003; 9 (03) 505-515
- 29 Purba ABU. Comparison of Freeze-Dried Bovine Bone, Decellularized Freeze-Dried Bovine Bone, and Deproteinized Bovine Bone Material Scaffolds Morphology [Thesis]. Surabaya: Universitas Airlangga; 2022
- 30 Murphy CM, Haugh MG, O'Brien FJ. The effect of mean pore size on cell attachment, proliferation and migration in collagen-glycosaminoglycan scaffolds for bone tissue engineering. Biomaterials 2010; 31 (03) 461-466
- 31 Oryan A, Moshiri A. Recombinant fibroblast growth protein enhances healing ability of experimentally induced tendon injury in vivo. J Tissue Eng Regen Med 2014; 8 (06) 421-431
- 32 Hanks T, Atkinson BL. Comparison of cell viability on anorganic bone matrix with or without P-15 cell binding peptide. Biomaterials 2004; 25 (19) 4831-4836
- 33 Abdelmoneim D, Porter GC, Coates DE. et al. The effect of low-processing temperature on the physicochemical and mechanical properties of bovine hydroxyapatite bone substitutes. Materials (Basel) 2022; 15 (08) 2798
- 34 Oryan A, Alidadi S, Moshiri A, Maffulli N. Bone regenerative medicine: classic options, novel strategies, and future directions. J Orthop Surg Res 2014; 9 (01) 18
